Avastin plus chemotherapy prolonged PFS in patients with previously treated GBM

Avastin plus chemotherapy demonstrated a 2.7-month increase (4.2 months vs 1.5 months) in median PFS compared with chemotherapy alone (HR=0.52 [95% CI, 0.41–0.64]).[1]

GBM=glioblastoma; PFS=progression-free survival; HR=hazard ratio; CI=confidence interval.